AVIR
Atea Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$4.15
+0.13 (+3.23%)
Open$4.05
Previous Close$4.02
Day High$4.17
Day Low$3.91
52W High$42.64
52W Low$24.62
Volume—
Avg Volume593.3K
Market Cap324.23M
P/E Ratio—
EPS$-1.08
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,009.6% upside
Current
$4.15
$4.15
Target
$46.05
$46.05
$31.54
$46.05 avg
$64.23
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 49.99M | 49.26M | 44.69M |
| Net Income | 8.60M | 11.50M | 7.45M |
| Profit Margin | 17.2% | 23.3% | 16.7% |
| EBITDA | 12.90M | 12.92M | 13.20M |
| Free Cash Flow | 9.03M | 8.66M | 6.93M |
| Rev Growth | +19.5% | +7.9% | +2.0% |
| Debt/Equity | 0.36 | 0.36 | 0.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |